Release Date: 11/03/20 17:14 Summary: Half Yearly Report and Accounts Price Sensitive: No Download Document 2.09MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%